BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 15618584)

  • 1. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells.
    Dormer RL; McNeilly CM; Morris MR; Pereira MM; Doull IJ; Becq F; Mettey Y; Vierfond JM; McPherson MA
    Pflugers Arch; 2001; 443 Suppl 1():S117-20. PubMed ID: 11845316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells.
    Dragomir A; Björstad J; Hjelte L; Roomans GM
    Biochem Biophys Res Commun; 2004 Sep; 322(2):447-51. PubMed ID: 15325250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil acts as potentiator and corrector of CFTR but might be not suitable for the treatment of CF lung disease.
    Leier G; Bangel-Ruland N; Sobczak K; Knieper Y; Weber WM
    Cell Physiol Biochem; 2012; 29(5-6):775-90. PubMed ID: 22613978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic signaling underlies CFTR control of human airway epithelial cell volume.
    Braunstein GM; Zsembery A; Tucker TA; Schwiebert EM
    J Cyst Fibros; 2004 Jun; 3(2):99-117. PubMed ID: 15463893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.
    Antigny F; Norez C; Cantereau A; Becq F; Vandebrouck C
    Respir Res; 2008 Oct; 9(1):70. PubMed ID: 18973672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
    Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
    J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
    Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
    N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
    Lubamba B; Lecourt H; Lebacq J; Lebecque P; De Jonge H; Wallemacq P; Leal T
    Am J Respir Crit Care Med; 2008 Mar; 177(5):506-15. PubMed ID: 18006891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
    Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
    Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
    Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
    Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
    Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
    Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
    Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
    J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
    Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
    Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.